Table 3.
Prognostic value of PCDH8 methylation in serum for the BCR-free survival in univariate and multivariate analysis.
| Varivale | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Exp (B) | 95% CI | P | Exp (B) | 95% CI | P | |
| Age | 0.869 | 0.684–10.491 | 0.742 | |||
| PSA | 1.537 | 1.074–6.582 | 0.039 | 1.122 | 0.796–5.357 | 0.238 |
| Clinical stage | 3.257 | 1.376–10.427 | 0.005 | 2.523 | 1.032–4.763 | 0.025 |
| Gleason score | 1.365 | 0.692–9.248 | 0.156 | |||
| Lymph node status | 2.482 | 1.418–7.315 | 0.017 | 1.476 | 1.107–4.572 | 0.042 |
| Surgical margin status | 1.137 | 0.844–4.036 | 0.365 | |||
| PCDH8 methylation | 3.864 | 1.462–8.962 | <0.001 | 3.147 | 1.152–7.961 | 0.007 |